Drugs Health Medical Pharma

Novo Nordisk’s Ozempic receives EMA’s nod for chronic kidney disease treatment

HQ Team December 13, 2024: Novo Nordisk has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP).

Read More